Little DG - Search Results

1

Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta.

Little DG, Peacock L, Mikulec K, Kneissel M, Kramer I, Cheng TL, Schindeler A, Munns C. Little DG, et al. Bone. 2017 Aug;101:96-103. doi: 10.1016/j.bone.2017.04.016. Epub 2017 Apr 29. Bone. 2017. PMID: 28461254

2

Bisphosphonates and nephrocalcinosis in a rabbit leg lengthening model: a histological and therapeutic comparison.

Williams PR, Smith NC, Cooke-Yarborough C, Little DG. Williams PR, et al. Among authors: little dg. Pharmacol Toxicol. 2001 Sep;89(3):149-52. doi: 10.1034/j.1600-0773.2001.d01-150.x. Pharmacol Toxicol. 2001. PMID: 11589787

3

Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis. A study in immature rabbits.

Little DG, Cornell MS, Briody J, Cowell CT, Arbuckle S, Cooke-Yarborough CM. Little DG, et al. J Bone Joint Surg Br. 2001 Sep;83(7):1069-74. doi: 10.1302/0301-620x.83b7.10542. J Bone Joint Surg Br. 2001. PMID: 11603525

4

Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis.

Little DG, Smith NC, Williams PR, Briody JN, Bilston LE, Smith EJ, Gardiner EM, Cowell CT. Little DG, et al. J Bone Miner Res. 2003 Jul;18(7):1300-7. doi: 10.1359/jbmr.2003.18.7.1300. J Bone Miner Res. 2003. PMID: 12854841 Free article.

5

Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats.

Little DG, Peat RA, Mcevoy A, Williams PR, Smith EJ, Baldock PA. Little DG, et al. J Bone Miner Res. 2003 Nov;18(11):2016-22. doi: 10.1359/jbmr.2003.18.11.2016. J Bone Miner Res. 2003. PMID: 14606515 Free article.

6

Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis.

Smith EJ, McEvoy A, Little DG, Baldock PA, Eisman JA, Gardiner EM. Smith EJ, et al. Among authors: little dg. J Bone Miner Res. 2004 Oct;19(10):1698-705. doi: 10.1359/JBMR.040709. Epub 2004 Jul 21. J Bone Miner Res. 2004. PMID: 15355565 Free article.

7

Short-term safety assessment in the use of intravenous zoledronic acid in children.

Högler W, Yap F, Little D, Ambler G, McQuade M, Cowell CT. Högler W, et al. J Pediatr. 2004 Nov;145(5):701-4. doi: 10.1016/j.jpeds.2004.06.066. J Pediatr. 2004. PMID: 15520785

8

Quantification of metaphyseal modeling in children treated with bisphosphonates.

Ward K, Cowell CT, Little DG. Ward K, et al. Among authors: little dg. Bone. 2005 Jun;36(6):999-1002. doi: 10.1016/j.bone.2005.02.016. Bone. 2005. PMID: 15869921

9

Zoledronic acid improves femoral head sphericity in a rat model of perthes disease.

Little DG, McDonald M, Sharpe IT, Peat R, Williams P, McEvoy T. Little DG, et al. J Orthop Res. 2005 Jul;23(4):862-8. doi: 10.1016/j.orthres.2004.11.015. Epub 2005 Feb 25. J Orthop Res. 2005. PMID: 16023001 Free article.

10

Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits.

Smith EJ, Little DG, Briody JN, McEvoy A, Smith NC, Eisman JA, Gardiner EM. Smith EJ, et al. Among authors: little dg. J Bone Miner Res. 2005 Oct;20(10):1731-41. doi: 10.1359/JBMR.050604. Epub 2005 Jun 13. J Bone Miner Res. 2005. PMID: 16160731 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters